COVID-19 is an emerging, rapidly evolving situation.
What people with cancer should know: https://www.cancer.gov/coronavirus
Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers
Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
NCL News Archive
Thursday, February 2, 2017
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
The first issue of ACS Nano for 2017 features an article on the “Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.” The article, co-authored by NCL’s Senior Immunologist, Marina Dobrovolskaia, along with several other well-known names in the field, summarizes the topics of discussion from a recent meeting on the subject. The two-day workshop was held... View Post
Tuesday, December 6, 2016
Nature Reviews Materials
NCL’s Director, Scott McNeil, recently published a Correspondence article in Nature Reviews Materials. “Evaluation of nanomedicines: Stick to the basics”, was written in response to another recent Nature Reviews Materials article, Wilhelm, et al, Nature Reviews Materials, 2016, 1, 16014. The Wilhelm, et al. article provides a retrospective analysis of nanoparticle drug... View Post
Tuesday, December 6, 2016
Join our LinkedIn group on Nanomedicine Preclinical Development
NCL has created a focus group on LinkedIn, designed to connect researchers within the nanotech field. The aim of the group will be to discuss the latest news, trends, and issues of Nanomedicine Preclinical Development.
Join here: https://www.linkedin.com/groups/8555666
Tuesday, December 6, 2016
Nature Reviews publication
The NCL has recently published a review article entitled “Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer” in Nature Reviews Clinical Oncology. The review highlights current nanomedicine strategies being used to target one of the most devastating cancers.
Find the Advance Online publication here: http://www.nature.com/nrclinonc/journal/vaop/... View Post
Monday, November 28, 2016
Nanomedicine Pharmacokinetics Publication
NCL’s Sr. Principal Scientist in Pharmacology & Toxicology, Dr. Stephan Stern, has spearheaded several important publications on the complexity of nanomedicine pharmacokinetics and the importance of measuring all drug fractions—nanomedicine encapuslated, protein-bound, and free unbound drug—when evaluating nanomedicine PK. The most recent of these publications is entitled “When Is It... View Post
Monday, November 28, 2016
NCL Lessons Learned Workshop Videocast
The NCL recently hosted its 8th edition of the popular Lessons Learned Workshop (LLW) seminar series. This year’s meeting was condensed into an intensive half-day series of talks covering topics such as strategies for evaluating batch-to-batch consistency, surface characterization, nanomaterial ADME/Tox and PK, sterility and endotoxin contamination, immunotoxicity, and linking physicochemical... View Post
Monday, September 26, 2016
AAPS Journal Themed Issue
The AAPS Journal is compiling a themed issue entitled “Nanotechnology in Complex Drug Products: Learning from the Past, Preparing for the Future.” The issues aims to discuss characterization, manufacturing, and regulatory challenges in nanotechnology drug products. NCL’s contribution to this collection, “Early Development Challenges for Drug Products Containing Nanomaterials” has just been... View Post